Clinical trials
In Utero Procedure Affecting Fetus or Newborn clinical trials
Below are recruiting in utero procedure affecting fetus or newborn clinical trials, each written for real people, not researchers. We’re tracking 218 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04664556Recruiting
Study of severe pneumococcal infections in children
This study tracks cases of invasive pneumococcal disease (a serious infection) in children and newborns. It may help clinicians better understand how these infections happen and guide future prevention and treatment.
CréteilAges 1 day–18 years - NCT04664569Recruiting
Study of treatments for bacterial meningitis in children
This study enrolls children and newborns with suspected or confirmed bacterial meningitis. The goal is to understand and improve care for serious infections that affect the lining around the brain.
CréteilAges 1 day–18 years - NCT04905537Recruiting
Genetic screening for newborns after a serious pregnancy loss
This trial looks at doing early genetic testing in newborns/early life cases after a serious pregnancy loss, to learn whether genetics can help understand why it happened. If you have the right timing and sample availability, the results may help future “more precise” care planning and research.
Shanghai, Shanghai MunicipalityAges Up to 3 months - NCT07697872Recruiting
The Dirty Nappy Study for babies with liver problems
This study looks at babies with possible liver problems (cholestasis) who have been referred to the Birmingham Liver Unit. Researchers want to collect information from nappy (diaper) samples to better understand these conditions.
BirminghamAges Up to 11 years - NCT04952870Recruiting
Study breathing treatment and early immunity in newborns after COVID
This study looks at how newborns’ bodies are affected by COVID-19 around birth and whether a breathing support treatment (inhaled nitric oxide) changes outcomes. It also compares COVID-exposed babies and a similar group of babies without COVID who are not receiving the breathing treatment.
LilleAges Up to 3 months - NCT04975178RecruitingPhase 3
Test of a TB vaccine for newborns in sub-Saharan Africa
This Phase 3 study tests whether MTBVAC can safely protect newborn babies from tuberculosis and whether it helps the baby’s immune system learn to fight TB. If you enroll, the goal is to see safety and immune response in real newborn settings in sub-Saharan Africa.
Worcester, Western CapeAges 5 minutes–1 week - NCT04984967Recruiting
Testing a tiny guide for placing IV lines in newborns
This study looks at whether using a very small “micro-guide” helps place a peripheral IV (a small vein line) in newborns more safely or easily. It may help staff reduce problems with IV placement in the neonatal unit.
MontpellierAges Up to 4 weeks - NCT05081258Recruiting
Tests presurgery shaping for newborn cleft lip and palate growth
This study looks at whether a presurgery orthodontic shaping method affects how newborns with a cleft lip and palate grow over time. It may help clinicians decide on the best early treatment approach.
Erlangen, BavariaAges 1 day–2 years - NCT05207852Recruiting
Dexamethasone study for preterm labor lung development
This trial studies how well dexamethasone works and how it behaves in the body when given during preterm labor to help the baby’s lungs mature. You may be able to join if you’re pregnant between 24–36 weeks and are receiving the study treatment per their schedule.
BeijingAges 20–40 - NCT05395195RecruitingPhase 3
Erythropoietin for newborn brain injury in low-resource settings
This Phase 3 trial studies whether erythropoietin (a medicine related to red-blood-cell growth) can improve outcomes for newborns with moderate to severe brain injury after birth. The study focuses on babies born in low- and middle-income countries and aims to reduce harm from this early brain condition.
DhakaAges 1 hour–6 hours - NCT05454332RecruitingPhase 4
Caffeine for premature babies right after birth
This study tests whether caffeine given to very premature babies around the time they move from fetus to newborn stage can improve outcomes. It may help babies who need support as they breathe and adapt after birth.
Porto Alegre, Rio Grande do SulAges Up to 2 hours - NCT05537389Recruiting
Test safety of IV central lines in newborns
This study checks how safe it is to place and use a central venous catheter (a special IV line) in newborns in the NICU. It may help doctors use these lines more safely when they’re needed.
Torino, ItaliaAges 1 hour–3 months - NCT05604846Recruiting
Probiotic drops for very preterm babies in Scandinavia
This trial studies whether giving probiotic supplements to extremely preterm newborns helps improve health outcomes. It’s meant for babies born very early, and the results could help guide safer early nutrition and care.
Solna, Stockholm CountyAges 5 months–6 months - NCT05610085RecruitingPhase 2
Levetiracetam for newborn seizures: dose-finding study
This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.
San Diego, CaliforniaAges Up to 1 month - NCT05612256Recruiting
Measuring breathing pressure in newborns using EIT
This study uses a painless electrical sensor method (EIT) to help find the best positive end-expiratory pressure setting for newborns on a ventilator. The goal is to improve how the ventilator supports breathing in the early days of life.
BaselAges birth–4 weeks - NCT05700760Recruiting
ROSE program study to prevent postpartum depression
This study tests whether a program called ROSE can help prevent postpartum depression after delivery. If you’re pregnant, you may be asked to complete questionnaires and be reached by phone for study steps.
Flint, MichiganAges 18 years+ - NCT05702203Recruiting
Music therapy for newborns with congenital heart disease
This trial tests whether creative music therapy can help newborn babies who have congenital heart disease (CHD) while they are in intensive care. It focuses on babies who are otherwise very young and in the NICU or PICU, regardless of CHD severity.
ZurichAges 1 minute–4 weeks - NCT05767476Recruiting
Testing cooling treatment after lack of oxygen at birth
This trial studies outcomes in newborns who had breathing problems from low oxygen before or during birth and were treated with a cooling therapy (therapeutic hypothermia). It may help doctors understand which babies benefit most and what recovery looks like over time.
RomeAges 10 minutes–6 hours - NCT05778188RecruitingPhase 2
RLS-0071 for newborns with moderate or severe HIE
This trial studies whether RLS-0071 is safe and can help some newborns with moderate or severe hypoxic-ischemic encephalopathy (HIE), a brain injury caused by low oxygen around birth. Babies in the study also receive standard whole-body cooling (therapeutic hypothermia), and the researchers will watch for side effects and early signs of benefit.
Little Rock, ArkansasAges Up to 10 hours - NCT05843851Recruiting
Newborn screening for rare cystinosis and hyperoxaluria
This study offers genetic screening to newborns to look for two rare metabolic conditions. It helps doctors find these conditions earlier, so treatment can start sooner if needed.
Hanover, Lower SaxonyAges 1 day–3 days - NCT05861531Recruiting
Oral stimulation and language support for preterm feeding
This study tests whether a feeding-focused therapy that includes mouth stimulation and language support helps preterm babies feed more effectively. It may be most helpful for babies born very early who are learning to feed safely and comfortably.
Providence, Rhode IslandAges 5 months–7 months - NCT05889507RecruitingPhase 3
Cooling treatment for newborns with mild brain injury
This Phase 3 study tests whether cooling a newborn’s body can help babies with mild brain injury after a difficult birth. It aims to see if cooling improves brain-related outcomes compared with standard care.
NaplesAges 1 hour–6 hours - NCT05907317RecruitingPhase 3
Protecting the brains of very young newborns on breathing machines
This Phase 3 study tests ways to protect brain health in newborns who are very premature or recently born and need a breathing machine through a tube. It may help reduce the risk of brain injury while they receive intensive care.
MadridAges birth–4 weeks - NCT05960929RecruitingPhase 3
Breathing support for premature babies with lung distress
This Phase 3 trial tests whether InfasurfAero™ (a type of surfactant given as aerosol) works better than a sham treatment in preterm babies with respiratory distress syndrome (RDS). It aims to improve breathing in the first hours of life for babies who need CPAP.
Phoenix, ArizonaAges 7 months–8 months
Hear when a new In Utero Procedure Affecting Fetus or Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for in utero procedure affecting fetus or newborn?
- Yes. Clin2 currently lists 218 recruiting in utero procedure affecting fetus or newborn studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a in utero procedure affecting fetus or newborn trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a in utero procedure affecting fetus or newborn trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.